ConductScience.org, home

Paper32166319

The Integrase Inhibitors Dolutegravir and Raltegravir Exert Proadipogenic and Profibrotic Effects and Induce Insulin Resistance in Human/Simian Adipose Tissue and Human Adipocytes.

Gorwood J and 16 others. Clin Infect Dis, 2020. Cited by 136 papers, by iCite.

Cite this record

ConductScience Library. The Integrase Inhibitors Dolutegravir and Raltegravir Exert Proadipogenic and Profibrotic Effects and Induce Insulin Resistance in Human/Simian Adipose Tissue and Human Adipocytes. Papers, record 32166319. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/32166319

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
The Integrase Inhibitors Dolutegravir and Raltegravir Exert Proadipogenic and Profibrotic Effects and Induce Insulin Resistance in Human/Simian Adipose Tissue and Human Adipocytes.
PubMed
Journal
Clin Infect Dis
PubMed
Year
2020
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
136
iCite
Relative citation ratio, by iCite
7.49
iCite
Revised in PubMed
2026-01-27
PubMed

Authors17

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Gorwood JJennifer
2Bourgeois CChristine
3Pourcher VValérie
4Pourcher GGuillaume
5Charlotte FFrédéric
6Mantecon MMatthieu
7Rose CCindy
8Morichon RRomain
9Atlan MMichael
10Le Grand RRoger
11Desjardins DDelphine
12Katlama CChristine
13Fève BBruno
14Lambotte OOlivier
15Capeau JJacqueline
16Béréziat VVéronique
17Lagathu CClaire

Source PubMed

Download CSV of authors

Topics14

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
HIV InfectionsMajor topic
HIV Integrase InhibitorsMajor topic
Insulin ResistanceMajor topic
Adipocytes
Adipose Tissue
Drug Resistance, Viral
Heterocyclic Compounds, 3-Ring
Humans
Integrase Inhibitors
Oxazines
Piperazines
Pyridones
Raltegravir Potassium
Dolutegravir

Source PubMed

Download CSV of topics

Cited by87

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 136 citations.

PMIDTitleJournalYearIn PapersSource
42821149A novel synergistic phycobiliprotein combination against HIV-1 shows potent antiviral activity.AMB Express2026https://conductscience.org/library/papers/42821149PubMed
42819026Metabolic dysfunction-associated steatotic liver disease in people living with HIV: mechanisms, diagnosis, and management.Front Immunol2026https://conductscience.org/library/papers/42819026PubMed
42577690Longitudinal Hepatic and Metabolic Trajectories Following Dolutegravir Initiation in Antiretroviral Therapy (ART)-Naïve People Living With HIV: A Prospective Cohort Study From South India.Cureus2026https://conductscience.org/library/papers/42577690PubMed
42544255Dolutegravir-Associated Dyslipidemia and Atherogenic Lipid Changes Among Treatment-Naïve People Living With HIV: A 12-Month Prospective Cohort Study From Southern India.Cureus2026https://conductscience.org/library/papers/42544255PubMed
42471828Semi-automated, evidence-based workflow for selection of reference chemicals for the validation of NAMs: a case study with the adipogenesis assay.NAM J2026https://conductscience.org/library/papers/42471828PubMed
42467806Weight gain and obesity management in people with HIV: pathophysiology, antiretroviral therapy effects, and clinical strategies.Top Antivir Med2026https://conductscience.org/library/papers/42467806PubMed
42466959Dolutegravir population pharmacokinetics in racially, sex- and age-diverse and antiretroviral therapy-experienced adults with HIV in the United States.HIV Med2026https://conductscience.org/library/papers/42466959PubMed
42436668Prevalence and associated factors of malnutrition among adults living with HIV on ART: a pilot study.Metabol Open2026https://conductscience.org/library/papers/42436668PubMed
42378059A distinct form of fat fibrosis is linked to insulin resistance in people with HIV.JCI Insight2026https://conductscience.org/library/papers/42378059PubMed
42366600Longitudinal Serum Metabolomic Signatures Related to Integrase Strand Transfer Inhibitors-Associated Weight Gain in Women with HIV Enrolled in the MACS/WIHS Combined Cohort Study.J Infect Dis2026https://conductscience.org/library/papers/42366600PubMed
42084659Increased Adiposity and Dyslipidemia in Young Men Living with HIV Compared to Matched PrEP Users: A Cross-Sectional Study.Adv Ther2026https://conductscience.org/library/papers/42084659PubMed
41911940Incident diabetes after switching to integrase strand transfer inhibitors in people with HIV in the USA and Canada: a cohort study.Lancet HIV2026https://conductscience.org/library/papers/41911940PubMed
41880067To Switch or not to Switch: are there any Antiretroviral Strategies to Attenuate Weight Gain in People with HIV?Curr HIV/AIDS Rep2026https://conductscience.org/library/papers/41880067PubMed
41779383Cardiometabolic impact of dolutegravir as second-line therapy: secondary analysis of a randomized controlled trial.AIDS2026https://conductscience.org/library/papers/41779383PubMed
41743543Type 2 diabetes in people living with HIV: epidemiology, mechanisms, sex differences and early-life determinants.Front Endocrinol (Lausanne)2026https://conductscience.org/library/papers/41743543PubMed
41711779Combined tenofovir, lamivudine, and dolutegravir treatment increases leptin and FABP4 expression in human subcutaneous adipose tissue.Einstein (Sao Paulo)2026https://conductscience.org/library/papers/41711779PubMed
41600910Reversible Effects of Integrase Inhibitors on Newly Differentiated Adipocytes.Viruses2026https://conductscience.org/library/papers/41600910PubMed
41462126A systematic review assessing body mass index and waist circumference as predictors for the development of type 2 diabetes mellitus among people living with HIV on antiretroviral therapy.BMC Infect Dis2025https://conductscience.org/library/papers/41462126PubMed
41295281Metabolomic Profile of Weight Gain of People Living with HIV Treated with Integrase Strand Transfer Inhibitor Regimens Reveals Dysregulated Lipid Metabolism and Mitochondrial Dysfunction.Metabolites2025https://conductscience.org/library/papers/41295281PubMed
41252191Altered Lipid and Neurotransmitter Metabolism as Potential Mechanisms of Weight Gain in Women With HIV Initiating INSTIs in a Pilot Study.J Acquir Immune Defic Syndr2026https://conductscience.org/library/papers/41252191PubMed

See all 87 cited byDownload CSV of cited by

Genes2

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
ADIPOQ9370PubTator's text mininghttps://conductscience.org/library/genes/9370NCBI Gene
INS3630PubTator's text mininghttps://conductscience.org/library/genes/3630NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/32166319

GET https://conductscience.org/api/papers/v1/32166319/cited_by?page=2